Both cancer specialists and PCPs had general knowledge about prostate cancer survivorship care including assessing for treatment side effects and managing complications (eg, erectile dysfunction) and monitoring for recurrence (eg, serial PSA testing). This evidence concerns the gene KLK3 and prostate carcinoma.